Medical Data Vision Co., Ltd. (3902) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medical Data Vision Co., Ltd. (3902:JPX), powered by AI.

Current Price
¥1,684
Consensus Target
¥420 (-75.1%)
Analyst Coverage
1 analysts
Sector
Healthcare
What is the Medical Data Vision Co., Ltd. stock price forecast?

1 analysts have a consensus target of ¥420, representing -75.1% upside from the current price.

What is Medical Data Vision Co., Ltd. insider trading activity?

View the latest insider trading data for Medical Data Vision Co., Ltd. on Alpha Lenz.

What is Medical Data Vision Co., Ltd.'s P/E ratio?

View Medical Data Vision Co., Ltd.'s valuation metrics on Alpha Lenz.

Medical Data Vision Co., Ltd.

JPX · 3902
¥1,684+0(+0.00%)Market closedJPX regular session 09:00–15:00 JST
Ask about Medical Data Vision Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Medical Data Vision Co., Ltd.'s ROE is 9.1%. Explore profitability and growth together.

Ask for details

Company Overview

Medical Data Vision Co., Ltd. is a leading healthcare technology company that focuses on the management and analysis of medical data. The primary function of the company is to collect and utilize healthcare data to enhance the efficiency and effectiveness of medical services and facilitate better decision-making in the healthcare industry. This Japanese company specializes in the integration of Electronic Health Records (EHRs), providing valuable insights to both medical institutions and pharmaceutical companies. By transforming raw medical data into actionable analytics, Medical Data Vision plays a crucial role in the healthcare value chain, impacting sectors such as hospital administration, drug development, and preventive medicine. The company's offerings help to streamline healthcare operations, optimize patient care, and support clinical research. In the rapidly evolving landscape of digital health, Medical Data Vision stands out as a pivotal player in leveraging big data to foster innovation and improve health outcomes. Its role in the financial markets is underscored by growing interest in health informatics and technology-driven healthcare solutions, reflecting the increasing importance of data in shaping future healthcare paradigms.

SectorHealthcare
IndustryHealth Information Services
Employees315

Company Statistics

FY 2025

Profile

N/AMarket Cap
¥6,539,159,000Revenue
0.00Shares Out
315Employees

Margins

69.63%Gross
11.48%EBITDA
5.34%Operating
1.01%Pre-Tax
4.22%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

2.32%Rev 3Yr
7.38%Rev 5Yr
-41.64%Op Inc 3Yr
-21.15%Op Inc 5Yr
-31.44%Net Inc 3Yr
-17.03%Net Inc 5Yr

Returns

5.80%ROA
9.06%ROE
7.34%ROIC

Financial Health

¥1,713,216,000Cash & Cash Equivalents
¥-46,016,000Net Debt
53.59%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Medical Data Vision Co., Ltd. (ticker: 3902) is a company listed on JPX in the Healthcare sector (Health Information Services). It has approximately 315 employees.

The current price is 1,684 with a P/E ratio of -x and P/B of -x.

ROE is 9.06% and operating margin is 5.34%. Annual revenue is $6.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Medical Data Vision Co., Ltd. (3902) Stock Forecast 2026 ¥1,684 — Price, Financials & Analyst Targets | Alpha Lenz